Oral anticoagulation with coumarins for patients with atrial fibrillation and chronic kidney disease?

被引：0
|
作者：
Hoerl, Walter H. [1 ]
机构：
[1] Dept Med 3, Div Nephrol & Dialysis, A-1090 Vienna, Austria
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 2009年 / 121卷 / 21-22期
关键词：
HEMODIALYSIS-PATIENTS; DIALYSIS PATIENTS; DRUG-METABOLISM; WARFARIN; RISK; CYP2C9; MORTALITY; ASSOCIATION; MANAGEMENT; AMERICANS;
D O I：
10.1007/s00508-009-1272-x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：668 / 672
页数：5
相关论文
共 50 条
  • [31] Oral Anticoagulation in Chronic Kidney Disease and Atrial Fibrillation Biased Results Owing to Competing Interests? Reply
    Heine, Gunnar H.
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2018, 115 (37): : 606 - 607
  • [32] Oral Anticoagulation for Atrial Fibrillation Thromboembolism Prophylaxis in the Chronic Kidney Disease Population: the State of the Art in 2019
    Zhang, Lane
    Steckman, David A.
    Adelstein, Evan C.
    Schulman-Marcus, Joshua
    Loka, Alfred
    Mathew, Roy O.
    Venditti, Ferdinand J.
    Sidhu, Mandeep S.
    CARDIOVASCULAR DRUGS AND THERAPY, 2019, 33 (04) : 481 - 488
  • [33] Oral Anticoagulation for Atrial Fibrillation Thromboembolism Prophylaxis in the Chronic Kidney Disease Population: the State of the Art in 2019
    Lane Zhang
    David A. Steckman
    Evan C. Adelstein
    Joshua Schulman-Marcus
    Alfred Loka
    Roy O. Mathew
    Ferdinand J. Venditti
    Mandeep S. Sidhu
    Cardiovascular Drugs and Therapy, 2019, 33 : 481 - 488
  • [34] Atrial Fibrillation in Patients with Chronic Kidney Disease
    Kotalczyk, Agnieszka
    Ding, Wern Yew
    Wong, Christopher F.
    Rao, Anirudh
    Gupta, Dhiraj
    Lip, Gregory Y. H.
    CARDIOLOGY CLINICS, 2021, 39 (03) : 435 - 446
  • [35] Response to "Direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease"
    Bhatia, Harpreet S.
    Bailey, Joseph
    Unlu, Ozan
    Hoffman, Katherine
    Kim, Robert J.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2020, 43 (02): : 267 - 267
  • [36] Risks of anticoagulation in patients with chronic kidney disease and atrial fibrillation: More than just bleeding?
    Gutierrez, Orlando M.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2019, 3 (02) : 147 - 148
  • [37] Anticoagulation in patients with non-valvular atrial fibrillation (nvAF) and chronic kidney disease (CKD)
    Zeymer, Uwe
    Bonnemeier, Hendrik
    Wanner, Christoph
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (23) : 1642 - 1649
  • [38] Use of oral anticoagulation and association to outcomes in atrial fibrillation patients who develop chronic kidney disease: a nationwide cohort study
    Bonde, A. Nissen
    Lip, G. Y. H.
    Kamper, A. L.
    Gislason, G.
    Torp-Pedersen, C.
    Hlatky, M.
    Olesen, J. B.
    EUROPEAN HEART JOURNAL, 2018, 39 : 820 - 820
  • [39] Moderate chronic kidney disease contributes to major bleeding event in patients with atrial fibrillation on anticoagulation
    Nakamura, R.
    Matsue, Y.
    Mizukami, A.
    Ohno, M.
    Suzuki, M.
    Matsumura, A.
    Hashimoto, Y.
    EUROPEAN HEART JOURNAL, 2012, 33 : 342 - 343
  • [40] Thromboembolic and Bleeding Risk in Atrial Fibrillation Patients with Chronic Kidney Disease: Role of Anticoagulation Therapy
    Magnocavallo, Michele
    Bellasi, Antonio
    Mariani, Marco Valerio
    Fusaro, Maria
    Ravera, Maura
    Paoletti, Ernesto
    Di Iorio, Biagio
    Barbera, Vincenzo
    Della Rocca, Domenico Giovanni
    Palumbo, Roberto
    Severino, Paolo
    Lavalle, Carlo
    Di Lullo, Luca
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (01) : 1 - 18
12345